Use of Dalfampridine in Primary Lateral Sclerosis
Clinical trial NCT02868567 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02868567
- Sponsor
- Hospital for Special Surgery, New York
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2026-07-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.